Trial intelligence / Profile preview

Curcumin-Piperine and Vitamin D in SLE

NCT05430087Phase 2Completed

Sponsor
Dr. Saiful Anwar Hospital
Start
Mar 2020
Primary completion
Jan 2022
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 2 trial of curcumin in systemic lupus erythematosus (SLE), sponsored by Dr. Saiful Anwar Hospital. Started Mar 2020; status: completed.

02

Drugs

curcumin
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT05430087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05430087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call